Ready-to-use ketamine premix formulation
AssigneeInforlife SA
InventorSergio DUSCI
Life of this patent
Estimating the term…
Abstract
The invention relates to a sterile, ready-to-use, stable aqueous solution of ketamine suitable for direct intravenous infusion to a patient in need thereof, wherein the composition is disposed within a sealed infusion container as a premixture. The invention further relates to aqueous solutions of ketamine that are free of antimicrobials such as benzethonium chloride and are shelf-stable. The pharmaceutical compositions can be used, for example, wherein the subject is in need of anesthesia for a diagnostic or a surgical procedure.
Claims30
A ketamine product comprising an aqueous ketamine solution comprising about 0.5 to about 2.5 mg/mL ketamine, a tonicity adjusting agent, and water for injection, wherein the ketamine product is sterile and ready-to-use (RTU).
A ketamine product comprising an aqueous ketamine solution comprising about 0.5 to about 2.5 mg/mL ketamine, a tonicity adjusting agent, and water for injection, wherein the ketamine solution is preservative-free, and wherein the ketamine solution is contained in a terminally sterilized, ready-to-use infusion container.
A ketamine product comprising an aqueous ketamine solution comprising about 0.5 to about 2.5 mg/mL ketamine, a tonicity adjusting agent, and water for injection, wherein the ketamine solution is contained in an infusion bag, wherein the ketamine product has been aseptically filled, and wherein the ketamine product is ready-to-use (RTU).
Dependencies are inferred from the claim text.